Printer Friendly

PERSEPTIVE BIOSYSTEMS, INC. ANNOUNCES PUBLIC OFFERING OF TWO MILLION SHARES AT $18 PER SHARE

 CAMBRIDGE, Mass., March 4 /PRNewswire/ -- PerSeptive Biosystems, Inc. (NASDAQ: PBIO) announced today that it has sold 2 million shares of the company's common stock in a public offering at a price of $18 per share.
 Managing underwriters for the offering are Alex. Brown & Sons Incorporated and Cowen & Company. If the underwriters' over-allotment option is exercised, a current shareholder of the company will sell up to an additional 300,000 shares of common stock.
 PerSeptive Biosystems designs, manufactures and markets proprietary products and systems for the purification and analysis of biomolecules. These bioseparations products are designed to reduce significantly the time and cost required for the development and manufacture of biopharmaceuticals. The company's current and planned products for the purification and analysis of biomolecules are based on three interrelated core technologies: Perfusion Chromatography(R), ImmunoDetection(tm) and Rational Surface Design(tm).
 Prospectuses may be obtained from Alex. Brown & Sons Incorporated, 135 E. Baltimore Street, Baltimore, MD., 21202, Attn: David DiPietro or Cowen & Company, Financial Square, 27th Fl., New York, N.Y., 10005, Attn: Jack Dunphy.
 This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
 -0- 3/4/93
 /CONTACT: Noubar B. Afeyan, president and CEO, or Robert A. Fein, vice president and CFO, 617-621-1787, PerSeptive Biosystems, Inc./
 (PBIO)


CO: PerSeptive Biosystems ST: Massachusetts IN: MTC SU: OFR

TM -- NE002 -- 2826 03/04/93 09:10 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 4, 1993
Words:269
Previous Article:KOHL'S CORPORATION JANUARY SALES REPORT
Next Article:BLUE CROSS AND BLUE SHIELD OF NEW JERSEY AND AMERICAN EXPRESS ANNOUNCE AGREEMENT TO DEVELOP HEALTH CARE PAYMENT SERVICE
Topics:


Related Articles
ROBERT B. ANACONE NAMED SENIOR VICE PRESIDENT, MARKETING AND SALES AT PERSEPTIVE BIOSYSTEMS
PERSEPTIVE BIOSYSTEMS ANNOUNCES THIRD QUARTER RESULTS
PERSEPTIVE BIOSYSTEMS, INC. FILES REGISTRATION STATEMENT WITH SEC FOR PUBLIC OFFERING OF 2 MILLION SHARES OF COMMON STOCK
PERSEPTIVE BIOSYSTEMS ANNOUNCES ACQUISITION OF VESTEC CORPORATION
PERSEPTIVE BIOSYSTEMS REPORTS RESULTS FOR FIRST FISCAL QUARTER OF 1996
PERSEPTIVE BIOSYSTEMS' STOCKHOLDERS APPROVE ACQUISITION OF PERSEPTIVE TECHNOLOGIES II CORPORATION
PerSeptive Biosystems, Inc. Announces Departure of Robert Anacone
PerSeptive Biosystems Announces Advances in Human Genome Analysis
PerSeptive Biosystems Reports Fourth Quarter Fiscal 1996 Results
PerSeptive Biosystems Reports Results for Second Fiscal Quarter of 1997; Product Sales up 20%; EPS of $1.02 Includes Gain from ChemGenics Merger

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters